Business Context and Reporting Period
This Form 6-K filing by Virax Biolabs Group Ltd (a Cayman Islands exempted company) is dated September 4, 2026. The report concerns an amendment to the Company's At The Market Offering Agreement with H.C. Wainwright & Co., LLC, originally entered into on January 22, 2024.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital raising activities.
- Previous Shares Sold: $3,658,152 of Ordinary Shares have been sold under the Sales Agreement prior to this filing.
- New Offering Capacity: The maximum aggregate offering amount is increased to $2,070,060.20.
Material Changes
The primary material change is the filing of a "Sticker Prospectus Supplement" to amend the existing Registration Statement on Form F-3. This amendment increases the maximum aggregate amount of Ordinary Shares the Company may offer and sell through the Sales Agent to $2,070,060.20. This new limit is in addition to the $3,658,152 of shares previously sold under the agreement.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding business outlook, guidance, or specific operational risks. It includes standard legal disclaimers stating that the report does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful without registration. The filing incorporates by reference the original Sales Agreement and a legal opinion from Ogier regarding the legality of the share issuance.
Investor Verification Checklist
- Verify the total number of shares outstanding and the current market price to assess the dilution impact of the new $2,070,060.20 offering capacity.
- Review the original Sales Agreement (Exhibit 10.1) to understand the commission structure and sales terms with H.C. Wainwright & Co., LLC.
- Confirm the Company's current cash position and capital needs, as this filing indicates a continued strategy of raising capital via the ATM program.
- Check subsequent filings to determine if and when shares are actually sold under this new limit.